Home Institutions UCSF clinical trials Institution Directory
Clinical trials at UCSF Sites in San Francisco, CA
Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.
ClinicalTrials.gov public records Last synced Oct 21, 2026, 2:41 PM EDT
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official matching trials
1391
Current sort
Recently updated
Campus scope
UCSF, San Francisco, CA
Additional filters apply within this campus.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Showing 397–408 of 1,391 matching trials with a site at UCSF, San Francisco, CA.
Live ClinicalTrials.gov results.
Local aggregate panels are unavailable or hidden for filtered views. The result list above identifies its data source.
Live official records
Conditions Healthy Volunteer, Older Adults (65-85 Years)
Interventions Psilocybin (Usona Institute) Drug
Lead sponsor University of Colorado, Denver Other
Eligibility 65 Years to 85 Years
Enrollment 40 participants
Healthy volunteers Accepts healthy volunteers
Timeline 2026 – 2028
U.S. locations 6
States / cities San Francisco, California • Aurora, Colorado • Atlanta, Georgia + 3 more
Conditions Small Cell Lung Cancer Metastatic or Locally Advanced, Neuroendocrine Cancer, Metastatic Neuroendocrine Prostate Cancer, Metastatic Advanced Poorly Differentiated Gastroenteropancreatic Neuroendocrine Carcinoma, Metastatic Advanced Merkel Cell Carcinoma, Locally Advanced Large Cell Neuroendocrine Carcinoma of the Lung, Locally Advanced Extrapulmonary Neuroendocrine Carcinoma, Locally Advanced Neuroendocrine Prostate Cancer, Locally Advanced Poorly Differentiated Gastroenteropancreatic Neuroendocrine, Locally Advanced Merkel Cell Carcinoma, Metastatic Large Cell Neuroendocrine Carcinoma of the Lung
Interventions BL-M14D1 Drug
Lead sponsor SystImmune Inc. Industry
Eligibility 18 Years and older
Enrollment 120 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2027
U.S. locations 24
States / cities Huntsville, Alabama • Glendale, California • Long Beach, California + 18 more
Conditions Cancer, Thoracic Cancer, Gynecologic Cancer, Head and Neck Cancer, Gastrointestinal Cancer
Interventions Blood Specimen Collection, Stool Specimen Collection, Quality of Life (QOL) Questionnaires Procedure · Other
Lead sponsor University of California, San Francisco Other
Eligibility 18 Years and older
Enrollment 125 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2024 – 2028
U.S. locations 1
States / cities San Francisco, California
Conditions Kidney Stones
Interventions Patient Navigation Other
Lead sponsor University of California, San Francisco Other
Eligibility 18 Years and older
Enrollment 31 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2026 – 2027
U.S. locations 1
States / cities San Francisco, California
Conditions Postpartum Bladder Dysfunction, Post-prostatectomy Bladder Dysfunction, Bladder Dysfunction
Interventions DFree Non-Invasive Bladder Ultrasound, Perifit Kegel Exerciser, Exit interview Other
Lead sponsor University of California, San Francisco Other
Eligibility 18 Years and older
Enrollment 25 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2024 – 2027
U.S. locations 1
States / cities San Francisco, California
Conditions Bladder Cancer, Squamous Cell Carcinoma of the Lung, Esophageal Squamous Cell Carcinoma, Tongue Squamous Cell Carcinoma, Cutaneous Squamous Cell Cancer, Penile Squamous Cell Carcinoma, Anal Squamous Cell Carcinoma, Vulvar Squamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Vaginal Squamous Cell Carcinoma, Urethral Squamous Cell Carcinoma
Interventions EVOLVE104 Drug
Lead sponsor EvolveImmune United, Inc Industry
Eligibility 18 Years and older
Enrollment 160 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2031
U.S. locations 16
States / cities Duarte, California • Los Angeles, California • San Francisco, California + 10 more
Conditions HSIL, High Grade Squamous Intraepithelial Lesion, HPV-Related Squamous Cell Carcinoma, Anal HSIL
Interventions EXE-346 Probiotic, Placebo, Usual Care High Resolution Anoscopy (HRA) Drug · Procedure
Lead sponsor University of California, San Francisco Other
Eligibility 21 Years and older
Enrollment 90 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2026 – 2028
U.S. locations 1
States / cities San Francisco, California
Conditions Infertility, Infertility Secondary, Infertility Unexplained, Anovulation, Fertility Disorders, Reproductive Issues
Interventions Zymot Multi sperm separation device, Density gradient centrifugation Device · Other
Lead sponsor University of California, San Francisco Other
Eligibility 18 Years and older
Enrollment 270 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2023 – 2027
U.S. locations 1
States / cities San Francisco, California
Conditions Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma
Interventions Biospecimen Collection, Computed Tomography, Dabrafenib Mesylate, Echocardiography Test, Multigated Acquisition Scan, Positron Emission Tomography, Trametinib Dimethyl Sulfoxide Procedure · Drug
Lead sponsor National Cancer Institute (NCI) NIH
Eligibility 18 Years and older
Enrollment 280 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2014 – 2027
U.S. locations 752
States / cities Birmingham, Alabama • Anchorage, Alaska • Fairbanks, Alaska + 464 more
Conditions Non-muscle-invasive Bladder Cancer
Interventions Gemcitabine, Docetaxel, Bacillus Calmette Guerin Drug
Lead sponsor ECOG-ACRIN Cancer Research Group Network
Eligibility 18 Years and older
Enrollment 870 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2023 – 2030
U.S. locations 229
States / cities Birmingham, Alabama • Fairbanks, Alaska • Gilbert, Arizona + 163 more
Conditions Epilepsy, Lennox Gastaut Syndrome, Lennox-Gastaut Syndrome, Intractable, Seizures, Seizures, Generalized
Interventions RNS System Device
Lead sponsor NeuroPace Industry
Eligibility 12 Years and older
Enrollment 24 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2022 – 2026
U.S. locations 6
States / cities Birmingham, Alabama • San Francisco, California • Atlanta, Georgia + 2 more
Conditions Breast Cancer
Interventions Elacestrant, Anastrozole, Letrozole, Exemestane, Tamoxifen Drug
Lead sponsor Stemline Therapeutics, Inc. Industry
Eligibility 18 Years and older
Enrollment 4,220 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2024 – 2032
U.S. locations 176
States / cities Daphne, Alabama • Chandler, Arizona • Gilbert, Arizona + 139 more About this UCSF institution page
What this page lists ClinicalTrials.gov records that list UCSF in San Francisco, CA as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
Site status A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
Where the data comes from Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.
Related: all institution pages , trials led by University of California, San Francisco at any site , browse by condition , or browse by U.S. city .